» Articles » PMID: 11870547

A Cyclin-dependent Kinase Inhibitor (p21(WAF1/CIP1)) Affects Thymidine Incorporation in Human Liver Cancer Cells

Overview
Journal Br J Cancer
Specialty Oncology
Date 2002 Mar 1
PMID 11870547
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

p21(WAF1/CIP1) is a universal cyclin-dependent kinase inhibitor. To investigate the role of p21(WAF1/CIP1) in proliferation of human liver cancer cells, we examined the expression of p53, p21(WAF1/CIP1), cdk2 and cdk4 expression in two human liver cancer cell lines (HepG2 and PLC/PRF/5 cells). The effects of p21(WAF1/CIP1) on [(3)H]thymidine incorporation and cdks were also examined in these cells. HepG2 cells expressed all these proteins with lower level of cdk4. PLC/PRF/5 cells expressed the other proteins except p21(WAF1/CIP1). Transfection of p21(WAF1/CIP1) gene inhibited [(3)H]thymidine incorporation of both cells with different extent. Although the transfection of p21(WAF1/CIP1) did not affect cdk2 and cdk4 expression, it did reduce cdk2 kinase activity by 20%. These results suggest that: (a) p21(WAF1/CIP1) involved in DNA synthesis of human liver cancer cells; (b) p21(WAF1/CIP1) could be a target gene for the treatment of human hepatocellular carcinoma.

Citing Articles

Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells.

Riedel R, Perez-Perez A, Carmona-Fernandez A, Jaime M, Casale R, Duenas J Sci Rep. 2019; 9(1):14193.

PMID: 31578445 PMC: 6775050. DOI: 10.1038/s41598-019-50648-5.


Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines.

Chuang T, Wu H, Min J, Diamond M, Azziz R, Chen Y Cancer Cell Int. 2017; 17:59.

PMID: 28572744 PMC: 5450260. DOI: 10.1186/s12935-017-0429-3.


Function of oval cells in hepatocellular carcinoma in rats.

Fang C, Gong J, Zhang W World J Gastroenterol. 2004; 10(17):2482-7.

PMID: 15300889 PMC: 4572146. DOI: 10.3748/wjg.v10.i17.2482.


Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Yang B, Guo M, Herman J, Clark D Am J Pathol. 2003; 163(3):1101-7.

PMID: 12937151 PMC: 1868243. DOI: 10.1016/S0002-9440(10)63469-4.

References
1.
Hui A, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S . Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas. Hepatology. 1997; 25(3):575-9. DOI: 10.1002/hep.510250314. View

2.
Warbrick E, Lane D, Glover D, Cox L . A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr Biol. 1995; 5(3):275-82. DOI: 10.1016/s0960-9822(95)00058-3. View

3.
Naka T, Toyota N, Kaneko T, Kaibara N . Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res. 1998; 18(1B):555-64. View

4.
Qin L, Ng I, Fan S, Ng M . p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer. 1998; 79(4):424-8. DOI: 10.1002/(sici)1097-0215(19980821)79:4<424::aid-ijc19>3.0.co;2-4. View

5.
Shima N, Stolz D, Miyazaki M, Gohda E, Higashio K, Michalopoulos G . Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor. J Cell Physiol. 1998; 177(1):130-6. DOI: 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.0.CO;2-H. View